C1Part 3Trading income

Annotations:
Modifications etc. (not altering text)

F2CHAPTER 6ATrade profits: R&D expenditure credits

Annotations:
Amendments (Textual)
F2

Pt. 3 Ch. 6A inserted (with effect in accordance with Sch. 15 para. 27 of the amending Act) by Finance Act 2013 (c. 29), Sch. 15 para. 1

Interpretation

104YInterpretation

1

In this Chapter the following terms have the same meaning as they have in Part 13 (additional relief for expenditure on R&D)—

  • F6claim notification” (see section 1142A),

  • F6claim notification period” (see section 1142A),

  • “large company” (see section 1122),

  • “payment period” (see section 1141),

  • “qualifying body” (see section 1142),

  • “relevant research and development” (see section 1042),

  • “research and development” (see section 1041),

  • F5R&D claim” (see section 1142B),

  • “small or medium-sized enterprise” (see section 1119).

2

The following sections apply for the purposes of this Chapter as they apply for the purposes of Part 13—

  • sections 1123 and 1124 (staffing costs),

  • sections 1125 F1to 1126B (software F3, data licences, cloud computing services or consumable items),

  • sections 1127 to 1132 (qualifying expenditure on externally provided workers),

  • sections 1133 to 1136 (sub-contractor payments),

  • section 1138 (“subsidised expenditure”),

  • section 1140 (relevant payments to the subjects of a clinical trial).

3

For the purposes of this Chapter two companies are members of the same group if they are members of the same group of companies for the purposes of Part 5 of CTA 2010 (group relief).

F44

References in this Chapter to expenditure incurred on payments (however expressed) are references to expenditure incurred on payments made before the making of a claim under this Chapter in relation to that expenditure.